Vorinostat enhances gefitinib‑induced cell death through reactive oxygen species‑dependent cleavage of HSP90 and its clients in non‑small cell lung cancer with the EGFR mutation
Keyword(s):
Keyword(s):
Keyword(s):
2018 ◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):